Delivery Order SPE2DR25D3005-SPE2DR26FP8NR
- Not listed
- The Defense Logistics Agency awarded a $1,588.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 70s, with a completion date of December 31, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio and aligns with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.92 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 70s, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement portfolio. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.94 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger prime contract vehicle with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Refresh Plus 0.5% eye drops (30 units). This firm fixed price, non-set-aside contract is scheduled for completion by August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical Supply Chain operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,275.48 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-unit dose) on May 15, 2025, with an ultimate completion date of May 16, 2025. The contract is priced on a firm fixed-price basis with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,145.00 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 12, 2025, with completion scheduled for November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,933.22 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,329.17 for Refresh Plus 0.5% eye drops (50 unit doses) with a completion date of December 19, 2025. This contract represents a firm fixed price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.99 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (70 individual unit doses) on December 29, 2025, with completion targeted for December 30, 2025. This competitively awarded, firm fixed price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which carries a potential value of $999,999,999.00 and extends through...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8NRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,014.02 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within the Defense Logistics Agency's medical procurement operations. This delivery order operates under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC vehicle enables the contractor to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. AmerisourceBergen's portfolio of federal contracts demonstrates its critical role as a major pharmaceutical distributor serving Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible and competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/11/26 |